Patients with Alzheimer’s Disease Have Increased Levels of Insulin-like Growth Factor-I in Serum but not in Cerebrospinal Fluid-Reference-Cited by-同舟云学术

Patients with Alzheimer’s Disease Have Increased Levels of Insulin-like Growth Factor-I in Serum but not in Cerebrospinal Fluid

Published:2020-05-05 Issue:1 Volume:75 Page:289-298
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Horvath Alexandra¹,Salman Zeinab¹,Quinlan Patrick¹,Wallin Anders²,Svensson Johan¹

Affiliation:

1. Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

2. Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference61 articles.

1. The many faces of insulin-like peptide signalling in the brain;Fernandez;Nat Rev Neurosci,2012

2. The role of liver-derived insulin-like growth factor-I;Ohlsson;Endocr Rev,2009

3. Neuronal activity drives localized blood-brain-barrier transport of serum insulin-like growth factor-I into the CNS;Nishijima;Neuron,2010

4. Endocrine, liver-derived IGF-I is of importance for spatial learning and memory in old mice;Svensson;J Endocrinol,2006

5. Loss of serum IGF-I input to the brain as an early biomarker of disease onset in Alzheimer mice;Trueba-Saiz;Transl Psychiatry,2013

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin-Like Growth Factor Signaling in Alzheimer’s Disease: Pathophysiology and Therapeutic Strategies;Molecular Neurobiology;2024-09-06

2. The Associations Between Serum Insulin-like Growth Factor-I, Brain White Matter Volumes, and Cognition in Mild Cognitive Impairment and Alzheimer’s Disease;Journal of Alzheimer's Disease;2024-05-14

3. Repositioning of Anti-Diabetic Drugs against Dementia: Insight from Molecular Perspectives to Clinical Trials;International Journal of Molecular Sciences;2023-07-14

4. Identification of the molecular mechanism of insulin-like growth factor-1 (IGF-1): a promising therapeutic target for neurodegenerative diseases associated with metabolic syndrome;Cell & Bioscience;2023-01-23

5. Neuroprotective effects of insulin-like growth factor-2 in 6-hydroxydopamine-induced cellular and mouse models of Parkinson’s disease;Neural Regeneration Research;2023